Levetiracetam USP RC A

Levetiracetam USP RC A is a chlorinated synthetic byproduct arising from the acetylation step in Levetiracetam production, featuring a (S)-2-oxo-4-(2-chloroacetylamino)butyl substituent on the pyrrolidone core. Its structure incorporates a chloroacetyl moiety in lieu of the native acetamide, creating a steric and electronic divergence from the parent compound. This impurity, formed via unintended chloroacetyl chloride coupling, exhibits distinct HPLC retention due to the chlorine atom's hydrophobicity. Serves as a reference standard for quantifying this specific process-related impurity in Levetiracetam active pharmaceutical ingredient (API) batches.